132 related articles for article (PubMed ID: 35124274)
1. Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling.
Cromwell EF; Sirenko O; Nikolov E; Hammer M; Brock CK; Matossian MD; Alzoubi MS; Collins-Burow BM; Burow ME
SLAS Discov; 2022 Apr; 27(3):191-200. PubMed ID: 35124274
[TBL] [Abstract][Full Text] [Related]
2. In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.
Matossian MD; Chang T; Wright MK; Burks HE; Elliott S; Sabol RA; Wathieu H; Windsor GO; Alzoubi MS; King CT; Bursavich JB; Ham AM; Savoie JJ; Nguyen K; Baddoo M; Flemington E; Sirenko O; Cromwell EF; Hebert KL; Lau F; Izadpanah R; Brown H; Sinha S; Zabaleta J; Riker AI; Moroz K; Miele L; Zea AH; Ochoa A; Bunnell BA; Collins-Burow BM; Martin EC; Burow ME
Clin Transl Oncol; 2022 Jan; 24(1):127-144. PubMed ID: 34370182
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME
BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999
[TBL] [Abstract][Full Text] [Related]
4. A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development.
Girard YK; Wang C; Ravi S; Howell MC; Mallela J; Alibrahim M; Green R; Hellermann G; Mohapatra SS; Mohapatra S
PLoS One; 2013; 8(10):e75345. PubMed ID: 24146752
[TBL] [Abstract][Full Text] [Related]
5. Bioactive three-dimensional silk composite in vitro tumoroid model for high throughput screening of anticancer drugs.
Arora D; Bhunia BK; Janani G; Mandal BB
J Colloid Interface Sci; 2021 May; 589():438-452. PubMed ID: 33485251
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of canine mammary tumoroids for translational research.
Raffo-Romero A; Aboulouard S; Bouchaert E; Rybicka A; Tierny D; Hajjaji N; Fournier I; Salzet M; Duhamel M
BMC Biol; 2023 Feb; 21(1):23. PubMed ID: 36737789
[TBL] [Abstract][Full Text] [Related]
7. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
[TBL] [Abstract][Full Text] [Related]
8. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine.
Kalla J; Pfneissl J; Mair T; Tran L; Egger G
Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38806997
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery.
Vamvakidou AP; Mondrinos MJ; Petushi SP; Garcia FU; Lelkes PI; Tozeren A
J Biomol Screen; 2007 Feb; 12(1):13-20. PubMed ID: 17166827
[TBL] [Abstract][Full Text] [Related]
10. Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells.
Gautam P; Karhinen L; Szwajda A; Jha SK; Yadav B; Aittokallio T; Wennerberg K
Mol Cancer; 2016 May; 15(1):34. PubMed ID: 27165605
[TBL] [Abstract][Full Text] [Related]
11. Application of tumoroids derived from advanced colorectal cancer patients to predict individual response to chemotherapy.
Yao L; Zao XL; Pan XF; Zhang HG; Wang FJ; Qiao PF
J Chemother; 2023 Apr; 35(2):104-116. PubMed ID: 35285783
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of cancer stem cell-based tumoroids as an osteosarcoma model.
Ozturk S; Gorgun C; Gokalp S; Vatansever S; Sendemir A
Biotechnol Bioeng; 2020 Aug; 117(8):2527-2539. PubMed ID: 32391924
[TBL] [Abstract][Full Text] [Related]
13. Characterization of in vitro 3D cultures.
Mousavi N
APMIS; 2021 Aug; 129 Suppl 142():1-30. PubMed ID: 34399444
[TBL] [Abstract][Full Text] [Related]
14. Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine.
Hirokawa Y; Clarke J; Palmieri M; Tan T; Mouradov D; Li S; Lin C; Li F; Luo H; Wu K; Faux M; Tan CW; Lee M; Gard G; Gibbs P; Burgess AW; Sieber OM
Commun Biol; 2021 Sep; 4(1):1067. PubMed ID: 34518628
[TBL] [Abstract][Full Text] [Related]
15. Knockout of MMP3 Weakens Solid Tumor Organoids and Cancer Extracellular Vesicles.
Taha EA; Sogawa C; Okusha Y; Kawai H; Oo MW; Elseoudi A; Lu Y; Nagatsuka H; Kubota S; Satoh A; Okamoto K; Eguchi T
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429403
[TBL] [Abstract][Full Text] [Related]
16. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
Matossian MD; Burks HE; Bowles AC; Elliott S; Hoang VT; Sabol RA; Pashos NC; O'Donnell B; Miller KS; Wahba BM; Bunnell BA; Moroz K; Zea AH; Jones SD; Ochoa AC; Al-Khami AA; Hossain F; Riker AI; Rhodes LV; Martin EC; Miele L; Burow ME; Collins-Burow BM
Breast Cancer Res Treat; 2018 Jun; 169(2):381-390. PubMed ID: 29392581
[TBL] [Abstract][Full Text] [Related]
17. Melatonin blunted the angiogenic activity in 3D colon cancer tumoroids by the reduction of endocan.
Narmi MT; Shoja HM; Haiaty S; Mahdipour M; Rahbarghazi R
Cancer Cell Int; 2023 Jun; 23(1):118. PubMed ID: 37337165
[TBL] [Abstract][Full Text] [Related]
18. A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.
Shee K; Wells JD; Ung M; Hampsch RA; Traphagen NA; Yang W; Liu SC; Zeldenrust MA; Wang L; Kalari KR; Yu J; Boughey JC; Demidenko E; Kettenbach AN; Cheng C; Goetz MP; Miller TW
Clin Cancer Res; 2020 Jan; 26(1):159-170. PubMed ID: 31558472
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel.
Gangapuram M; Mazzio EA; Redda KK; Soliman KFA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299315
[TBL] [Abstract][Full Text] [Related]
20. The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids.
Truelsen SLB; Mousavi N; Wei H; Harvey L; Stausholm R; Spillum E; Hagel G; Qvortrup K; Thastrup O; Harling H; Mellor H; Thastrup J
PLoS One; 2021; 16(7):e0253258. PubMed ID: 34234354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
